Outcome measure | Evidence | Implications |
---|---|---|
Patient-oriented evidence | ||
Reversal of neuromuscular block by rocuronium or vecuronium | Multiple randomized clinical trials and comparison to antagonists | Efficient reversor of neuromuscular block and superior to antagonists regarding efficacy |
Recommended doses for profound, deep and moderate neuromuscular block (immediate reversal following 1.2 mg/kg rocuronium, PTC 1–2, TOF-C 2) | Multiple randomized clinical trials | Recommended doses are currently under postmarketing surveillance (Phase IV) |
Doses for shallow neuromuscular block (TOF-C 4, TOF ratio 0.5) | Single center randomized trials | Further studies (including safety) pending |
Disease-oriented evidence | ||
Renal disease | Multicenter parallel-group trial | 2 mg/kg sugammadex is efficient in patients with renal failure (creatinine clearance <30 mL/min), however current recommendations are to use sugammadex only if creatinine clearance >30 mL/min |
Obese patients | Single center randomized trials (heterogeneous comparison groups) | Doses according to ideal body weight +40% instead of actual body weight seems to be efficient for reversal |
RSI | Several randomized clinical trials | Combination of rocuronium and sugammadex are an alternative to succinylcholine for RSI |
Cesarian section | Several case series | Rocuronium and sugammadex might be a possible alternative to succinylcholine for RSI for patients undergoing a Cesarian section |
Electroconvulsive therapy | Single center trials (one randomized) | Rocuronium followed by 8 mg/kg sugammadex after electroconvulsive therapy is completed seems to be an alternative to succinylcholine |
Myasthenia gravis and muscular diseases | Case reports | Sugammadex seems to be efficient in such patients |
Allergic/anaphylactic reaction to rocuronium | Case reports and preclinical data | Might be useful however standard treatment of anaphylaxis has priority |
Economic evidence | Limited data. | Cost-effectiveness not proven. |
No prospective randomized economic trials | Economic benefits highly dependent on country, state or hospital reimbursement system as well as operation room logistics |
Abbreviations: PTC, post tetanic count; TOF-C, train of four count; RSI, rapid sequence induction.